{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:40:24Z","timestamp":1793209224878,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2021YFA1201100"],"award-info":[{"award-number":["2021YFA1201100"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010882","name":"TianJin Education Committee","doi-asserted-by":"publisher","award":["2024KJ186"],"award-info":[{"award-number":["2024KJ186"]}],"id":[{"id":"10.13039\/501100010882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303281"],"award-info":[{"award-number":["82303281"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271895"],"award-info":[{"award-number":["82271895"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21977080"],"award-info":[{"award-number":["21977080"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072752"],"award-info":[{"award-number":["82072752"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82430057"],"award-info":[{"award-number":["82430057"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22377090"],"award-info":[{"award-number":["22377090"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030092"],"award-info":[{"award-number":["82030092"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M752394"],"award-info":[{"award-number":["2024M752394"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M742619"],"award-info":[{"award-number":["2023M742619"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.drup.2025.101252","type":"journal-article","created":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T13:43:39Z","timestamp":1746971019000},"page":"101252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["A novel platinum(IV) prodrug, gramine-Pt(IV) enhances chemoimmunotherapy by activating cGAS-STING and modulating TGF-\u03b2-MHC-I axis"],"prefix":"10.1016","volume":"81","author":[{"given":"Bowen","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7023-7159","authenticated-orcid":false,"given":"Yumin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihui","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2025.101252_bib1","doi-asserted-by":"crossref","first-page":"1178190","DOI":"10.3389\/fphar.2023.1178190","article-title":"The platinum coordination complex inhibits cell invasion-migration and epithelial-to-mesenchymal transition by altering the TGF-beta-SMAD pathway in colorectal cancer","volume":"14","author":"Abdulla","year":"2023","journal-title":"Front Pharm."},{"key":"10.1016\/j.drup.2025.101252_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aay6017","article-title":"Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics","volume":"5","author":"Alshetaiwi","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.drup.2025.101252_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202217233","article-title":"Oral Anticancer Heterobimetallic Pt(IV) -Au(I) Complexes Show High In Vivo Activity and Low Toxicity","volume":"62","author":"Babu","year":"2023","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"10.1016\/j.drup.2025.101252_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102701","article-title":"Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis","volume":"125","author":"Bartoletti","year":"2024","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.drup.2025.101252_bib5","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1053\/j.gastro.2024.05.032","article-title":"Organoids for Functional Precision Medicine in Advanced Pancreatic Cancer","volume":"167","author":"Boileve","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drup.2025.101252_bib6","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/neuonc\/now009","article-title":"A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma","volume":"18","author":"Brandes","year":"2016","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.drup.2025.101252_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.critrevonc.2004.08.008","article-title":"Recognition and processing of cisplatin- and oxaliplatin-DNA adducts","volume":"53","author":"Chaney","year":"2005","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.drup.2025.101252_bib8","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1039\/C8CC02791A","article-title":"Platinum(iv) prodrugs with long lipid chains for drug delivery and overcoming cisplatin resistance","volume":"54","author":"Chen","year":"2018","journal-title":"Chem. Commun. (Camb. )"},{"key":"10.1016\/j.drup.2025.101252_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/biom11111637","article-title":"Anticancer platinum drugs update","volume":"11","author":"Ciarimboli","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.drup.2025.101252_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-beta signaling in health, disease, and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.drup.2025.101252_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","article-title":"TGFbeta biology in cancer progression and immunotherapy","volume":"18","author":"Derynck","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101252_bib12","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1158\/1078-0432.CCR-22-0346","article-title":"SHR-1701, a Bifunctional Fusion Protein Targeting PD-L1 and TGFbeta, for Recurrent or Metastatic Cervical Cancer: A Clinical Expansion Cohort of a Phase I Study","volume":"28","author":"Feng","year":"2022","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.drup.2025.101252_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2015.04.001","article-title":"New mechanisms for old drugs: Insights into DNA-unrelated effects of platinum compounds and drug resistance determinants","volume":"20","author":"Gatti","year":"2015","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drup.2025.101252_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102925","article-title":"Cisplatin: The first metal based anticancer drug","volume":"88","author":"Ghosh","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.drup.2025.101252_bib15","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1021\/jm070280u","article-title":"Basis for design and development of platinum(IV) anticancer complexes","volume":"50","author":"Hall","year":"2007","journal-title":"J. Med Chem."},{"key":"10.1016\/j.drup.2025.101252_bib16","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/med.21360","article-title":"Recent advances in platinum (IV) complex-based delivery systems to improve platinum (II) anticancer therapy","volume":"35","author":"Han","year":"2015","journal-title":"Med Res Rev."},{"key":"10.1016\/j.drup.2025.101252_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101115","article-title":"Dynamic immunoediting by macrophages in homologous recombination deficiency-stratified pancreatic ductal adenocarcinoma","volume":"76","author":"Hong","year":"2024","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drup.2025.101252_bib18","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1158\/1078-0432.CCR-24-0468","article-title":"TGFbeta in pancreas and colorectal cancer: opportunities to overcome therapeutic resistance","volume":"30","author":"Johansen","year":"2024","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.drup.2025.101252_bib19","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1021\/acs.chemrev.5b00597","article-title":"The next generation of platinum drugs: targeted pt(ii) agents, nanoparticle delivery, and Pt(IV) prodrugs","volume":"116","author":"Johnstone","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.drup.2025.101252_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202311468","article-title":"Insertion of (Bioactive) equatorial ligands into platinum(IV) complexes","volume":"62","author":"Kastner","year":"2023","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"10.1016\/j.drup.2025.101252_bib21","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2025.101252_bib22","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","article-title":"and K.-. Investigators, Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Kelley","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.drup.2025.101252_bib23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/cac2.12539","article-title":"Immunologic tumor microenvironment modulators for turning cold tumors hot","volume":"44","author":"Khosravi","year":"2024","journal-title":"Cancer Commun. (Lond. )"},{"key":"10.1016\/j.drup.2025.101252_bib24","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1158\/0008-5472.CAN-12-3180","article-title":"Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells","volume":"73","author":"Kozono","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.drup.2025.101252_bib25","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1021\/acs.jmedchem.6b00478","article-title":"Gramine derivatives targeting Ca(2+) channels and Ser\/Thr phosphatases: a new dual strategy for the treatment of neurodegenerative diseases","volume":"59","author":"Lajarin-Cuesta","year":"2016","journal-title":"J. Med Chem."},{"key":"10.1016\/j.drup.2025.101252_bib26","doi-asserted-by":"crossref","first-page":"17063","DOI":"10.1038\/cddiscovery.2017.63","article-title":"The lauric acid-activated signaling prompts apoptosis in cancer cells","volume":"3","author":"Lappano","year":"2017","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.drup.2025.101252_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2019.100644","article-title":"Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer","volume":"46","author":"Leonetti","year":"2019","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drup.2025.101252_bib28","article-title":"Laminin gamma2-mediating T cell exclusion attenuates response to anti-PD-1 therapy","volume":"7","author":"Li","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.drup.2025.101252_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101152","article-title":"Breaking the barrier: epigenetic strategies to combat platinum resistance in colorectal cancer","volume":"77","author":"Luo","year":"2024","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drup.2025.101252_bib30","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101252_bib31","first-page":"3931","article-title":"Cisplatin and oxaliplatin cytotoxic effects in sensitive and cisplatin-resistant human cervical tumor cells: time and mode of application dependency","volume":"29","author":"Martelli","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.drup.2025.101252_bib32","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1038\/s41598-017-03864-w","article-title":"Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates","volume":"7","author":"Novohradsky","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drup.2025.101252_bib33","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1021\/jm0708275","article-title":"Calculation of lipophilicity of a large, diverse dataset of anticancer platinum complexes and the relation to cellular uptake","volume":"50","author":"Oldfield","year":"2007","journal-title":"J. Med Chem."},{"key":"10.1016\/j.drup.2025.101252_bib34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mrrev.2016.11.003","article-title":"Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer","volume":"771","author":"Perez-Ramirez","year":"2017","journal-title":"Mutat. Res Rev. Mutat. Res"},{"key":"10.1016\/j.drup.2025.101252_bib35","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ccell.2023.04.001","article-title":"Simultaneous targeting of PD-1 and IL-2Rbetagamma with radiation therapy inhibits pancreatic cancer growth and metastasis","volume":"41","author":"Piper","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101252_bib36","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1053\/j.gastro.2023.05.038","article-title":"Transforming growth factor-beta blockade in pancreatic cancer enhances sensitivity to combination chemotherapy","volume":"165","author":"Qiang","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drup.2025.101252_bib37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.phymed.2017.05.008","article-title":"Gramine inhibits angiogenesis and induces apoptosis via modulation of TGF-beta signalling in 7,12 dimethylbenz[a]anthracene (DMBA) induced hamster buccal pouch carcinoma","volume":"33","author":"Ramu","year":"2017","journal-title":"Phytomedicine"},{"key":"10.1016\/j.drup.2025.101252_bib38","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1093\/carcin\/17.12.2763","article-title":"In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells","volume":"17","author":"Saris","year":"1996","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.drup.2025.101252_bib39","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2409932","article-title":"and K.-. Investigators, overall survival with pembrolizumab in early-stage triple-negative breast cancer","author":"Schmid","year":"2024","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.drup.2025.101252_bib40","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJMoa2112651","article-title":"and K.-. Investigators, event-free survival with pembrolizumab in early triple-negative breast cancer","volume":"386","author":"Schmid","year":"2022","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.drup.2025.101252_bib41","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1023\/A:1008441416790","article-title":"Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days","volume":"9","author":"Sessa","year":"1998","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.drup.2025.101252_bib42","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/0960327119839185","article-title":"Lauric acid induce cell death in colon cancer cells mediated by the epidermal growth factor receptor downregulation: An in silico and in vitro study","volume":"38","author":"Sheela","year":"2019","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.drup.2025.101252_bib43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13045-025-01691-5","article-title":"The cGAS-STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications","volume":"18","author":"Shen","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.drup.2025.101252_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202400476","article-title":"A photodynamic and photochemotherapeutic platinum-iridium charge-transfer conjugate for anticancer therapy","volume":"63","author":"Shi","year":"2024","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"10.1016\/j.drup.2025.101252_bib45","doi-asserted-by":"crossref","first-page":"14246","DOI":"10.1002\/anie.201607380","article-title":"Base-resolution analysis of cisplatin-DNA adducts at the genome scale","volume":"55","author":"Shu","year":"2016","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"10.1016\/j.drup.2025.101252_bib46","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s43018-024-00775-4","article-title":"Tumor-associated macrophages restrict CD8(+) T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment","volume":"5","author":"Tharp","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.drup.2025.101252_bib47","article-title":"Epithelial-mesenchymal plasticity in cancer: signaling pathways and therapeutic targets","author":"Wang","year":"2024","journal-title":"MedComm (2020) 5"},{"key":"10.1016\/j.drup.2025.101252_bib48","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1021\/acsbiomaterials.7b00921","article-title":"Platinum (II) complex-nuclear localization sequence peptide hybrid for overcoming platinum resistance in cancer therapy","volume":"4","author":"Wlodarczyk","year":"2018","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.drup.2025.101252_bib49","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/sj.bjc.6605642","article-title":"and I. Committee of the national cancer research, guidelines for the welfare and use of animals in cancer research","volume":"102","author":"Workman","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2025.101252_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154779","article-title":"Gramine protects against pressure overload-induced pathological cardiac hypertrophy through Runx1-TGFBR1 signaling","volume":"114","author":"Xu","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.drup.2025.101252_bib51","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S1470-2045(22)00446-6","article-title":"Y. To, W.L. Redmond, B. Lee, J. Louie, E. Hansen, M.C. Solhjem, J. Cramer, W.J. Urba, M.J. Gough, M.R. Crittenden and K.H. Young, Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial","volume":"23","author":"Yamazaki","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.drup.2025.101252_bib52","article-title":"Platinum prodrug nanoparticles with COX-2 inhibition amplify pyroptosis for enhanced chemotherapy and immune activation of pancreatic cancer","volume":"36","author":"Yu","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.drup.2025.101252_bib53","doi-asserted-by":"crossref","first-page":"8790","DOI":"10.1021\/ja5038269","article-title":"Pt(IV) prodrugs designed to bind non-covalently to human serum albumin for drug delivery","volume":"136","author":"Zheng","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.drup.2025.101252_bib54","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1158\/1078-0432.CCR-15-1615","article-title":"Mutant p53 together with TGFbeta signaling influence organ-specific hematogenous colonization patterns of pancreatic cancer","volume":"23","author":"Zhong","year":"2017","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.drup.2025.101252_bib55","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.canlet.2020.11.049","article-title":"Low-dose carboplatin reprograms tumor immune microenvironment through STING signaling pathway and synergizes with PD-1 inhibitors in lung cancer","volume":"500","author":"Zhou","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2025.101252_bib56","doi-asserted-by":"crossref","DOI":"10.2174\/0115748928305100240613064754","article-title":"Adhesin component member STAG2 enhances cisplatin tolerance in colorectal cancer cells through the epithelial-mesenchymal transition pathway","author":"Zhou","year":"2024","journal-title":"Recent Pat. Anticancer Drug Discov."}],"updated-by":[{"DOI":"10.1016\/j.drup.2025.101268","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000}}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625000536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625000536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T01:18:03Z","timestamp":1754011083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764625000536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":56,"alternative-id":["S1368764625000536"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2025.101252","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel platinum(IV) prodrug, gramine-Pt(IV) enhances chemoimmunotherapy by activating cGAS-STING and modulating TGF-\u03b2-MHC-I axis","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2025.101252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101252"}}